45
Views
0
CrossRef citations to date
0
Altmetric
Psychiatry

Relationship between anhedonia and psychosocial functioning in post-COVID-19 condition: a post-hoc analysis

Anhedonia and psychosocial functioning in post-COVID-19 condition

, , , , , , , , , , , , , & show all
Received 21 Feb 2024, Accepted 25 Jun 2024, Published online: 08 Jul 2024

References

  • World Health Organization. WHO coronavirus (COVID-19) dashboard. World Health Organization; 2023 [cited November 4]. Available from: https://covid19.who.int/.
  • Ceban F, Ling S, Lui LMW, et al. Fatigue and cognitive impairment in post-COVID-19 Syndrome: a systematic review and meta-analysis. Brain Behav Immun. 2022;101:93–135. doi: 10.1016/j.bbi.2021.12.020.
  • Soriano JB, Murthy S, Marshall JC, WHO Clinical Case Definition Working Group on Post-COVID-19 Condition, et al. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102–e107. doi: 10.1016/S1473-3099(21)00703-9.
  • Ceban F, Nogo D, Carvalho IP, et al. Association between mood disorders and risk of COVID-19 infection, hospitalization, and death. JAMA Psychiatry. 2021;78(10):1079–1091. doi: 10.1001/jamapsychiatry.2021.1818.
  • Renaud-Charest O, Lui LMW, Eskander S, et al. Onset and frequency of depression in POST-COVID-19 syndrome: a systematic review. J Psychiatr Res. 2021;144:129–137. doi: 10.1016/j.jpsychires.2021.09.054.
  • Davis HE, McCorkell L, Vogel JM, et al. Long Covid: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133–146. doi: 10.1038/s41579-022-00846-2.
  • El Sayed S, Shokry D, Gomaa SM. Post‐Covid‐19 fatigue and anhedonia: a cross‐sectional study and their correlation to post‐recovery period. Neuropsychopharmacol Rep. 2020;41(1):50–55. doi: 10.1002/npr2.12154.
  • McIntyre RS, Woldeyohannes HO, Soczynska JK, et al. Anhedonia and cognitive function in adults with MDD: results from the International Mood Disorders Collaborative Project. CNS Spectr. 2016;21(5):362–366. doi: 10.1017/S1092852915000747.
  • Cooper JA, Arulpragasam AR, Treadway MT. Anhedonia in depression: biological mechanisms and computational models. Curr Opin Behav Sci. 2018;22:128–135. doi: 10.1016/j.cobeha.2018.01.024.
  • McIntyre RS, Loft H, Christensen MC. Efficacy of vortioxetine on anhedonia: results from a pooled analysis of short-term studies in patients with major depressive disorder. Neuropsychiatr Dis Treat. 2021;17:575–585. doi: 10.2147/NDT.S296451.
  • Zuckerman H, Pan Z, Park C, et al. Recognition and treatment of cognitive dysfunction in major depressive disorder. Front Psychiatry. 2018;9:655. doi: 10.3389/fpsyt.2018.00655.
  • ICH Official web site: ICH [Internet]. [cited 2024 Feb 20]. Available from: https://www.ich.org/page/efficacyguidelines
  • WMA declaration of Helsinki – ethical principles for medical research involving human subjects [Internet]. [cited 2024 Feb 20]. Available from: https://www.wma.net/policies-post/wma-declaration-ofhelsinki-ethical-principles-for-medical-research-involving-human-subjects/
  • McIntyre RS, Phan L, Kwan AT, et al. Vortioxetine for the treatment of post-Covid-19 condition: a randomized controlled trial. Brain. 2023;147(3):849–857. doi: 10.1093/brain/awad377.
  • Klok FA, Boon GJAM, Barco S, et al. The post-covid-19 functional status scale: a tool to measure functional status over time after COVID-19. Eur Respir J. 2020;56(1):2001494. doi: 10.1183/13993003.01494-2020.
  • Benkalfate N, Eschapasse E, Georges T, et al. Evaluation of the post-covid-19 functional status (PCFS) scale in a cohort of patients recovering from hypoxemic SARS-COV-2 pneumonia. BMJ Open Resp Res. 2022;9(1):e001136. doi: 10.1136/bmjresp-2021-001136.
  • Ameli R, Luckenbaugh DA, Gould NF, et al. Shaps-C: the Snaith-Hamilton Pleasure Scale modified for clinician administration. PeerJ. 2014;2:e429. doi: 10.7717/peerj.429.
  • Snaith RP, Hamilton M, Morley S, et al. A scale for the assessment of hedonic tone the snaith–hamilton pleasure scale. Br J Psychiatry. 1995;167(1):99–103. doi: 10.1192/bjp.167.1.99.
  • Bower M, Smout S, Donohoe-Bales A, et al. A hidden pandemic? An umbrella review of global evidence on mental health in the time of COVID-19. Front. Psychiatry. 2023;14:1107560. doi: 10.3389/fpsyt.2023.1107560.
  • Taquet M, Geddes JR, Husain M, et al. 6-month neurological and psychiatric outcomes in 236,379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(5):416–427. doi: 10.1016/S2215-0366(21)00084-5.
  • Toubasi AA, AbuAnzeh RB, Tawileh HBA, et al. A meta-analysis: the mortality and severity of COVID-19 among patients with mental disorders. Psychiatry Res. 2021;299:113856. doi: 10.1016/j.psychres.2021.113856.
  • Lira B, O'Brien JM, Peña PA, et al. Large studies reveal how reference bias limits policy applications of self-report measures. Sci Rep. 2022;12(1):19189. doi: 10.1038/s41598-022-23373-9.
  • Antonelli M, Penfold RS, Merino J, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22(1):43–55. doi: 10.1016/S1473-3099(21)00460-6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.